{
  "Cancer Histology Subtype (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2750, 
        2756
      ]
    }
  ], 
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2757, 
        2766
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2034, 
        2057
      ]
    }
  ], 
  "Comments Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2849, 
        2869
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1379, 
        1389
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2671, 
        2698
      ]
    }
  ], 
  "Laterality (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2700, 
        2704
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2821, 
        2825
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1593, 
        1622
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2778, 
        2804
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2741, 
        2749
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2705, 
        2711
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2806, 
        2812
      ]
    }
  ], 
  "Relative Location (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2724, 
        2737
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2826, 
        2839
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PATHLAB_LIS|HOSPITAL 5^9999^MOH|PIMS|CCO|20160503080102|400C02FBF4A7C87FAED742F377B59A3A4C219A6D|ORU^R01|999999999999|P|2.5|||\nPID|1||K999999^^^^CMR^HOSPITAL 5&9999&MOH~K999999^^^^MRN^HOSPITAL 5&9999&MOH~9999999999&XX&ON^^^^JHN||XXXXXXXXXX^XXXXX^^^^^||99999999|F|||99 XXXX XXXX^^XXXXXXXXX^XX^X9X 9X9^999|||||||||||||||||||N||\nOBR|1||16:SJ5833|11529-5^Surgical Pathology Study Report^LN^BX^Biopsy^L|||20160421|||29730^XXXX-XXX^XXXXXXXXX^XX-XXX^^^||||||||||||20160503|||C|||||||99999^XXXXX^XXXXXXXX^XXXXXXXXX^^^|\n\n\n\n\n\n\n\nPath Report.addendum spec\n\nHER2 and ESTROGEN RECEPTOR AND PROGESTERONE RECEPTOR\n             IMMUNOHISTOCHEMISTRY TESTS\n \nAs per your request, we have performed HER2 and ER/PR immunohistochemistry\ntests on the paraffin block received.\n \nTest done on block #CORE\n \nDetection System    Staining Intensity   Result\n \nDAKO Herceptest     1+           Negative\n \nLab reference range: >10% strong complete membranous staining (3+) is\n           considered positive for HER2.\n           The controls are adequate.\n \n           Antibody    % Cells        Result\n            Used     Nuclear\n                  Staining\nEstrogen Receptor   EP1     >90%         Positive\nProgesterone Receptor PGR636    Approx 30%      Positive\n \nLab reference range: <1% negative,\n           1-9% low positive\n           >10% positive\n           The controls are adequate.\n \n \n \nDIAGNOSIS:\n \n16:SJ5833, BLOCK # CORE (SELECTED BLOCK OF TUMOUR) LEFT BREAST: Using DAKO Herceptest\ndetection system, the infiltrating carcinoma cells are negative for HER2 (1).\n \nER Positive\nPGR Positive\n \nGG/ih\n\n\nPath report.gross description\n\nThe patient demographics and specimen identification on the requisition correspond to\nthat on the specimen container.\n \nThe specimen is received in formalin and labelled \"left breast 11 o'clock\". The\nspecimen is received in a white cassette labelled with the patient's name, date of\nbirth and \"x3\". Three cores are identified by the MLT at the time of embedding.\nSubmitted in total in the received cassette.\n\n\nPath report.relevant Hx\n\nCase Received From: Dr. R. Jesmin\nRadiologist: Dr. J. Kwok-Liu\nClinical Exam: Palpable\nReferral Source: \nFamily History: No\nHormone Replacement: No\nPrevious Biopsy: No\nImaging Modality: Mammography, ultrasound\nNumber of Cores: 3\nNumber of Cassettes: \nRadiology Findings: Mass, speculated\nLesion(s) Measurements: 16 x 10 x 17 mm\nIs Sample Representative: Yes\nCalcifications in Sample: No\nNo. of cores with calcification: \nNo. of cassettes with calcification: \nRadiologic Impression: (IV BIRADS) Suspicious\nPathologic Category: [n/a]\nMultidisciplinary Panel Recommendations: Given by radiology after correlation\n\n\nPath report.final diagnosis\n\nLeft Breast Core Biopsy at 11 O'clock:\n- Invasive ductal carcinoma.\n \nGG/aa\n\n\nPath report.site of origin\n\nBreast, Biopsy left at 11 o'clock 10 CFN\n\n\nPath report.comments\n\nISCHEMIC SPECIMEN TYPE Breast Core Biopsy\nISCHEMIC DATE PROCESSED 24/04/16\nDATE IN FORMALIN 21/04/16\nDATE TISSUE REMOVED 21/04/16\nISCHEMIC SIDE Left at 11 o'clock 10 CFN\nISCHEMIC SIGNATURE D, BOYLE\nTIME IN FORMALIN 1427\nTOTAL FIXATION TIME > 72 hours\nTIME TISSUE REMOVED 1422\n\n\n"
}